Please use this identifier to cite or link to this item:
|Title:||Immunotherapeutic strategies in antiphospholipid syndrome|
|Authors:||Hoi, Alberta Y;Ross, Laura;Day, Jessica;Buchanan, Russell RC|
|Citation:||Internal Medicine Journal 2016; 47(3): 250-256|
|Abstract:||Antiphospholipid syndrome (APS) is an autoimmune condition, characterized by the persistent presence of antiphospholipid antibodies (aPL) and either thrombosis or obstetric morbidity. The cornerstone of therapy is long-term anticoagulation to reduce morbidity and mortality; however, better understanding of the immunological pathways may direct us to develop future therapeutic strategies. We provide an overview of the current understanding of the immunopathogenesis of this perplexing condition and its associated morbidities and current evidence for some of the immunotherapeutic strategies.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.